Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation

Cell Biochemistry and Biophysics

Volumn 71, Issue 1, 2015, Pages 291-297

  Yang, Tianxin ^a   Lan, Jianping ^a   Huang, Qiang ^a   Chen, Xiaoyi ^a   Sun, Xiaodong ^a   Liu, Xing’e ^b   Yang, Ping ^a   Jin, Tao ^a   Wang, Shibing ^c   Mou, Xiaozhou ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b ZHEJIANG HOSPITAL   (China)

^c ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

AML; Apoptosis; Embelin; NF B; TRAIL

Indexed keywords

ADENOVIRIDAE;

ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; EMBELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE MYELOBLASTIC LEUKEMIA; ADENOVIRIDAE; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; DRUG EFFECTS; DRUG SCREENING; FEMALE; GENETICS; HL 60 CELL LINE; HUMAN; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOQUINONES; FEMALE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84920768014     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0197-9     Document Type: Article

References (22)

1. Burnett, A. K., et al. (2010). Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. Journal of Clinical Oncology,28(4), 586–595.
2. Buchner, T., et al. (2009). Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group. Journal of Clinical Oncology,27(1), 61–69.
3. Seo, O. W., et al. (2012). Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-kappaB-dependent cFLIP expression in HeLa cells. Experimental & Molecular Medicine,44(11), 653–664.
4. Neuzil, J., Swettenham, E., & Gellert, N. (2004). Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation. Biochemical and Biophysical Research Communications,314(1), 186–191.
5. Griffith, T. S., et al. (2011). Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. Apoptosis,16(1), 13–26.
6. Gupta, S. C., et al. (2011). Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax. Journal of Biological Chemistry,286(2), 1134–1146.
7. Jung, Y. H., et al. (2012). Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2. International Journal of Oncology,40(6), 1941–1948.
8. Du, Y. C., & Wie, J. S. (1963). Study of Vermifuges. I. Isolation of Embelin from the fruit of Mugua-Wha (Embelia Oblongifolia Hemsl.). Yao Xue Xue Bao,10, 578–580.
9. Dallacker, F., & Lohnert, G. (1972). Derivatives of methylenedioxybenzene. 35. A novel synthesis of 3,6 dihydroxy-2-ethyl-1,4-benzoquinone, embelin, vilangin, rapanone, dihydromaesaquinone, bhogatin, spinulosin and oosporein. Chemische Berichte,105(2), 614–624.
10. Wang, S. B., et al. (2012). Suppression of hepatoma carcinoma cell Bel-7404 by small molecule XIAP inhibitor Embelin through blocking NF-kappa B signaling pathway. Progress in Biochemistry and Biophysics,39(2), 161–167.
11. Franzoso, G., et al. (1997). Requirement for NF-kappaB in osteoclast and B-cell development. Genes & Development,11(24), 3482–3496.
12. Guo, A. K., et al. (2014). Loss of p53 enhances NF-κB—dependent lamellipodia formation. Journal of Cellular Physiology,229(6), 696–704.
13. Magrangeas, F., et al. (2013). Low level of NF-κb activity is associated with higher response rate to bortezomib-based induction therapy in patients with newly diagnosed multiple myeloma. Blood,122(21), 3106.
14. Cobler, L., et al. (2013). Activation of the NF-κB pathway downregulates TFF-1 in gastric carcinogenesis. Virchows Archiv,463(4), 497–507.
15. Seo, O. W., et al. (2012). Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-kappa B-dependent cFLIP expression in HeLa cells. Experimental & Molecular Medicine,44(11), 653–664.
16. Wang, S. B., et al. (2012). Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 Harboring TRAIL-IETD-smac gene with broad antitumor effect. Human Gene Therapy,23(9), 992–1002.
17. Han, J., et al. (2007). Kushen flavonoids induce apoptosis in tumor cells by inhibition of NF-kappa B activation and multiple receptor tyrosine kinase activities. Phytotherapy Research,21(3), 262–268.
18. Walczak, H., et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Medicine,5(2), 157–163.
19. Wang, S. B., et al. (2012). Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effect. Human Gene Therapy,23(9), 992–1002.
20. Falschlehner, C., et al. (2007). TRAIL signalling: decisions between life and death. International Journal of Biochemistry & Cell Biology,39(7–8), 1462–1475.
21. Ganten, T. M., et al. (2005). Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Hepatology,42(3), 588–597.
22. Dean, E. J., et al. (2010). A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. British Journal of Cancer,102(1), 97–103.